Share
The hemoglobin A1c blood test is widely used to diagnose type 1 and type 2 diabetes but it is actually unable to detect the disease in most patients, according to a new study presented at ENDO 2019 in New Orleans, La. “Based on these findings, A1c should not be solely used to rule out diabetes,...
Share
On Thursday April 4, The American Journal of Managed Care will host a regional Institute for Value-Based Medicine® meeting on the advances in treatment and management to reduce cost and improve outcomes of patients with diabetes from 5:30-9:00 p.m. at The Statler Dallas in Texas. This meeting will feature four presenters: Endocrine Society member Jaime Davidson, MD,...
Share
Glucose monitoring systems can provide information on trends in glucose levels that can be a key in making dosing decisions. Specific to the newest entry, the Endocrine Society has issued a usage guide to make life easier for both clinicians and patients. High-tech options for diabetes management continue to proliferate so quickly that...
Share
Artificial intelligence – once only found in a Steven Spielberg movie – is being adopted by the healthcare industry more and more from improving diabetes outcomes to reducing unnecessary thyroid surgeries. As these technologies improve, clinicians will soon have yet another ally to individualize patient care. Artificial intelligence. Machine learning. Those very phrases stir up...
Share
Individual genetic variation can be used to predict whether rosiglitazone will produce the unwanted side effect of increasing cholesterol levels in certain individuals, according to a study recently published in Cell Stem Cell. Researchers led by Mitchell Lazar, MD, PhD, director of the Institute for Diabetes, Obesity, and Metabolism in the Perelman School of Medicine at the...
Share
Patients with type 1 diabetes and poor blood sugar control face a higher risk of fragility fracture—any fall from standing height or less that results in a broken bone—than type 1 diabetes patients with good blood sugar control, according to a study published in The Journal of Clinical Endocrinology & Metabolism. “We investigated the association between...
Share
The predictive ability of a biomarker risk score beyond established risk factors may help identify women at risk of developing gestational diabetes (GDM) before conception and help with tailoring targeted prevention strategies, according to a study recently published in the Journal of the Endocrine Society. Researchers led by Sylvia E. Badon, PhD, of the Division...
Share
However, weight loss from weight cycling can reduce diabetes risk in people with obesity Weight cycling is associated with a higher risk of death, according to a new study published in The Journal of Clinical Endocrinology & Metabolism. Weight cycling, or the constant losing and gaining of weight (usually from diet), leads to adverse health outcomes....